Dr. David A. Mann currently serves as the Global Business Director for Drug Discovery and Bioengineering at Cellular Dynamics International. In that role, he is responsible for the generation of iPSC based disease models to support Pharma and Biotech partners’ discovery efforts and enable clinically translatable development. Dr. Mann has undergraduate degrees in Chemistry as well as Cellular and Molecular Biology and holds a PhD. in Organic Chemistry. Prior to joining CDI in 2013, Dr. Mann spent 10 years with Infinity Pharmaceuticals engaged in oncology drug discovery research and gained vast experience during that time, including: DOS library design, assay development and screening, hit to lead optimization, medicinal chemistry, and drug manufacture in support of clinical development. His diverse background and experience in the drug discovery process provide the framework and context to critically evaluate and engage in a wide range of collaborative activities aimed at addressing unmet clinical need.